22/07/2026
DMA FORUM UNDERTAKES STRATEGIC FACILITY TOUR OF HMA PHARMACEUTICALS TO PROMOTE LOCAL MANUFACTURING, STRENGTHEN HEALTHCARE SUPPLY CHAIN
The Forum of Heads of Drug Management Agencies (DMAs) in Nigeria has undertaken a strategic facility tour of HMA Pharmaceuticals in Ilorin, Kwara State, as part of efforts to promote local pharmaceutical manufacturing, strengthen Nigeria's healthcare supply chain, and deepen strategies that support the achievement of Universal Health Coverage (UHC).
The facility tour, organized by the African Resource Center for Excellence in Supply Chain Management (ARC_ESM), brought together Heads of Drug Management Agencies from across the country to explore opportunities for collaboration with indigenous pharmaceutical manufacturers and advance sustainable healthcare delivery through local production.
During the tour, members of the Forum were taken through HMA Pharmaceuticals' production facilities, where they witnessed firsthand the company's capacity in the manufacturing of high-quality pharmaceuticals and medical consumables that meet national standards. The Forum commended the management of HMA Pharmaceuticals for its commitment to excellence, innovation, quality assurance, and continuous improvement, describing the company's openness to collaboration and knowledge sharing as essential to strengthening Nigeria's pharmaceutical sector.
The Forum also expressed appreciation to the African Resource Center for Excellence in Supply Chain Management (ARC_ESM) for organizing the strategic visit and for its sustained technical support in strengthening Nigeria's health systems. The Forum acknowledged the programme's contributions to improving access to quality-assured medicines, enhancing supply chain management, and building institutional capacity across states, noting that such partnerships are critical to advancing healthcare reforms and expanding access to safe, effective, and affordable health commodities.
Speaking during the tour, the Director-General of the Plateau State Drugs and Medical Commodities Management Agency (PS-DMCMA), Pharm. Kim Jerry Bot, reaffirmed Plateau State's unwavering commitment to ensuring that citizens have access to quality, safe, effective, and affordable medicines and medical consumables.
He emphasized that strengthening local pharmaceutical manufacturing remains the most sustainable pathway to achieving medicine security, reducing dependence on imported medicines, creating employment opportunities, and guaranteeing uninterrupted access to essential healthcare commodities.
"The future of Nigeria's healthcare lies in strengthening local manufacturing. By supporting indigenous pharmaceutical industries, we are not only assuring quality and affordability but also building a more resilient supply chain capable of meeting the healthcare needs of our people," Pharm. Kim stated.
The Director-General further pledged to strengthen Plateau State's pharmaceutical supply chain by fostering strategic partnerships with credible local manufacturers and implementing innovative systems that will ensure the continuous availability of essential medicines and medical commodities across the state.
He also expressed profound appreciation to the Executive Governor of Plateau State, His Excellency Barr. Caleb Manasseh Mutfwang, for his unwavering commitment to improving healthcare delivery through strategic investments and policies that continue to create an enabling environment for reforms in the health sector.
The strategic facility tour underscored the growing commitment of Drug Management Agencies across Nigeria to leverage local manufacturing as a catalyst for medicine security, supply chain resilience, and sustainable healthcare development.
Participants reaffirmed that stronger collaboration between government institutions, development partners, and indigenous pharmaceutical manufacturers will play a vital role in ensuring equitable access to quality medicines and advancing Universal Health Coverage for all Nigerians.